Document ID: chunk:federal_register_of_legislation:F2025C00214:clause:1_61109:p1
Version: federal_register_of_legislation:F2025C00214
Segment Type: clause
Provision Reference: sch 1 cl 61109 (pt 1/4)
Character Range: 253327–256278

61109                                  Fluoroscopy in an angiography suite with image intensification, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this Group applies (R) (H)  262.80

Division 2.4—Group I4: nuclear medicine imaging

Subdivision A—General

2.4.1  Nuclear scanning services (other than PET nuclear scanning services) and adjunctive services
 (1) An item in Subgroup 1 or 3 of Group I4 applies only if:
 (a) the performance of the service does not involve the use of positron‑emission radio‑isotopes or a PET scanner; and
 (b) the service is performed under the supervision of a nuclear medicine credentialled specialist who is available to monitor and influence the conduct and diagnostic quality of the examination; and
 (c) a nuclear medicine credentialled specialist or a specialist in the specialty of diagnostic radiology is available, if necessary, to attend on the patient personally; and
 (d) the service is reported by a nuclear medicine credentialled specialist.
 (2) Paragraphs (1)(a) to (c) do not apply if the service is performed:
 (a) in an emergency; or
 (b) because of medical necessity, in a remote location.

2.4.1A  Restriction on items for stress myocardial perfusion studies—patients, requests and requirements
  Items 61324, 61329, 61345, 61349, 61357, 61394, 61398, 61406, 61410 and 61414 apply to a service performed on a patient only if:
 (a) one or more of subclauses 2.4.1B(1), (2) and (3) apply to the patient; and
 (b) the request for the service identifies any symptoms or clinical indications mentioned in those subclauses that apply to the patient; and
 (c) the service is performed in accordance with clause 2.4.1C.

2.4.1B  Stress myocardial perfusion studies—patients
  (1) This subclause applies to a patient if:
 (a) the patient displays symptoms of typical or atypical angina, including constricting discomfort of one or more of the following:
 (i) the front of the chest;
 (ii) the neck;
 (iii) the shoulders;
 (iv) the jaw;
 (v) the arms; or
 (b) the patient's symptoms are:
 (i) precipitated by physical exertion; or
 (ii) relieved within 5 minutes or less by rest or glyceryl trinitrate.
 (2) This subclause applies to a patient if:
 (a) the patient has known coronary artery disease; and
 (b) the patient displays one or more symptoms that are suggestive of ischaemia; and
 (c) the symptoms:
 (i) are not adequately controlled with medical therapy; or
 (ii) have evolved since the last functional study undertaken of the patient.
 (3) This subclause applies to a patient if one or more of the following clinical indications apply to the patient:
 (a) the patient does not have a known coronary artery disease but assessment indicates that resting twelve‑lead electrocardiogram changes are consistent with coronary artery disease or ischaemia;
 (b) coronary artery disease related lesions, of